Docetaxel versus Paclitaxel Combined with 5-FU and Leucovorin in Advanced Gastric Cancer: Combined Analysis of Two Phase II Trials-Reference-Cited by-同舟云学术

Docetaxel versus Paclitaxel Combined with 5-FU and Leucovorin in Advanced Gastric Cancer: Combined Analysis of Two Phase II Trials

Published:2009 Issue:4 Volume:41 Page:196
ISSN:1598-2998
Container-title:Cancer Research and Treatment
language:en
Short-container-title:Cancer Res Treat

Author:

Chon Hong Jae¹²,Rha Sun Young¹²,Im Chong Kun¹²,Kim Chan¹²,Hong Min Hee¹²,Kim Hye Ryun¹²,An Jung Ryun¹²,Noh Sung Hoon³,Chung Hyun Cheol¹²,Jeung Hei-Cheul¹²

Affiliation:

1. Department of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.

2. Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.

3. Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.

Publisher

Korean Cancer Association

Subject

Cancer Research,Oncology

Link

http://www.e-crt.org/upload/pdf/crt-41-196.pdf

Reference18 articles.

1. Docetaxel and Continuous-Infusion Fluorouracil Versus Epirubicin, Cisplatin, and Fluorouracil for Advanced Gastric Adenocarcinoma: A Randomized Phase II Study

2. Paclitaxel, 5-fluorouracil, and cisplatin combination chemotherapy for the treatment of advanced gastric carcinoma

3. Phase II Trial of the Combination of Paclitaxel and 5-Fluorouracil in the Treatment of Advanced Gastric Cancer

4. A phase II trial of paclitaxel and weekly 24 h infusion of 5-fluorouracil/folinic acid in patients with advanced gastric cancer

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the therapeutic potential of diterpenes in gastric cancer: Mechanisms, efficacy, and clinical prospects;Biomolecules and Biomedicine;2024-08-15

2. Treatment Outcome and Safety of the TCX Regimen for Advanced Gastric Cancer: A Prospective Cohort Study;Cancer Management and Research;2022-09

3. Drug-Induced Peripheral Neuropathy: Diagnosis and Management;Current Cancer Drug Targets;2021-07-20

4. Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy;Frontiers in Immunology;2021-02-04

5. Personalized Antibodies for Gastroesophageal Adenocarcinoma (PANGEA): A Phase II Study Evaluating an Individualized Treatment Strategy for Metastatic Disease;Cancer Discovery;2020-11-24